$AHR

American Healthcare REIT, Inc. (AHR): Results of Operations and Financial Condition

American Healthcare REIT, Inc. (AHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 ahr-ex99_2.htm EX-99.2 EX-99.2 Second Quarter 2026 Supplemental Talamore Senior Living Sun Prairie, WI Exhibit 99.2 Disclaimers Forward-Looking Statements Certain statements contained in this supplemental, filed in conjunction with the Second Quarter 2026 Earnings Press

Original reporting
Published Aug 6, 2026, 8:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AHR
Neutral
low confidence
Mentioned
$AHR
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AHRNeutralLow
01

Why it matters

Because the excerpt contains no numeric results, guidance, or balance-sheet changes, it does not provide a concrete trading catalyst.

02

Market read

This is a regulatory filing update, but the excerpt does not include the actual performance figures or guidance that would drive trading decisions.

03

What to watch

Traders should review the full Exhibit 99.2 for the actual Q2 2026 metrics (FFO/NFFO, NOI, occupancy, same-store NOI, leverage/net debt, and any full-year guidance changes).

Relevance 7/10Novelty 1/10Timing: Filed Aug 6, 2026, but excerpt provides no new results or guidance figures.

Background

The SEC 8-K indicates AHR issued a Second Quarter 2026 supplemental (Exhibit 99.2) alongside its earnings press release, but the provided content is only disclaimers and non-GAAP measure explanations.

Company-level read

Ticker impact

$AHRNeutralLow confidence
Context

AHR filed an 8-K with a Second Quarter 2026 supplemental on results of operations and financial condition, but the provided text contains only boilerplate definitions and disclaimers.

Expected impact

Likely negligible immediate impact from this excerpt; price reaction would depend on the missing exhibit 99.2 numeric results and guidance details.

Evidence & confidence

The excerpt is primarily forward-looking statement and non-GAAP measure definitions, with no disclosed earnings, FFO/NFFO, NOI, occupancy, guidance numbers, or balance-sheet changes.

Market effects

None from the provided excerpt; it does not disclose REIT operating trends, portfolio metrics, or guidance.

None from the provided excerpt.

None from the provided excerpt.

Counterpoint

The filing may still be market-moving, but the excerpt omits the actual results and guidance, so this brief cannot confirm any catalyst.

Key entities

  • American Healthcare REIT, Inc.

    Subject of the SEC 8-K filing and the accompanying Second Quarter 2026 supplemental exhibit.

  • SEC Form 8-K

    Regulatory filing type used to report results of operations and financial condition.

Related articles

$AHRMedAI 9/10

BofA Raises its Price Target on American Healthcare REIT (AHR)

On May 22, 2026, BofA raised its price target for American Healthcare REIT (AHR) to $67 from $63 and kept a Buy rating, saying it updated REIT models. AHR also announced a May 20 underwritten offering of 14M shares priced at $50.40. In Q1, normalized FFO was 50c (vs 47c consensus) and revenue was $650.77M (below $687.04M).

$RGAMed

REINSURANCE GROUP OF AMERICA INC (RGA): Results of Operations and Financial Condition

REINSURANCE GROUP OF AMERICA INC (RGA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 qfs2q26.htm EX-99.2 Document Exhibit 99.2 Quarterly Financial Supplement Second Quarter 2026 (Unaudited) World Headquarters Internet Address Contacts 16600 Swingley Ridge Road www.rgare.com Laura Cockrill Chesterfield, Missouri 63017 U.S.A. EVP, Chief Financial Officer

$PBYIMed

PUMA BIOTECHNOLOGY, INC. (PBYI): Results of Operations and Financial Condition

PUMA BIOTECHNOLOGY, INC. (PBYI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_973970.htm EXHIBIT 99.1 ex_973970.htm Exhibit 99.1 News Release Puma Biotechnology Reports Second Quarter 2026 Financial Results Raising 2026 Revenue and Net Income Guidance Based on Increased Demand for NERLYNX LOS ANGELES, Calif., Aug. 6, 2026 - Puma Biotechnology,

$GAINMed

GLADSTONE INVESTMENT CORPORATION\DE (GAIN): Results of Operations and Financial Condition

GLADSTONE INVESTMENT CORPORATION\DE (GAIN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 gain63026er8-kex991x8626.htm EX-99.1 Document Gladstone Investment Corporation Reports Financial Results for its First Quarter Ended June 30, 2026 MCLEAN, VA, August 6, 2026: Gladstone Investment Corporation (Nasdaq: GAIN) (the "Company") today announced earnings for it